Abstract. Reactive oxygen species (ROS) are involved in myocardial injury. ROS are known to inactivate lipid phosphatase and tension homolog on chromosome 10 (PTEN), an enzyme that increases apoptosis in neonatal cardiomyocytes. BpV(pic) and bpV(phen), two bisperoxovanadium molecules and PTEN inhibitors, may be involved in limiting myocardial infarction. To compare the protective effects of bpV(pic) and bpV(phen) on ROS-induced cardiomyocyte injury and their possible mechanisms, we selected two popular models of hypoxia/reoxygenation (H/R) and H 2 O 2 -induced injury in H9c2 cardiomyoblasts to investigate their effects against injury. We found that pre-treatment with bpV(pic) and bpV(phen) increased the viability and protected the morphology of H9c2 cells under the conditions of H/R and H 2 O 2 by inhibiting LDH release, apoptosis and caspases 3/8/9 activities. However, their respective inhibitory abilities in the two models were different, suggesting that the quantity of ROS from the two models might be different. However, the conflict between ROS and PTEN may affect the action of bpV(pic) and bpV(phen). Taken together, the results demonstrate that bpV(pic) and bpV(phen) have inhibitory effects on oxidative stress-induced cardiomyocyte injury that may be partially modulated by the action of ROS on PTEN.
Introduction
Myocardial ischemia/reperfusion injury (MIRI), which may lead to various complications, including myocardial infarction, cardiac contractile dysfunction and arrhythmia (1) (2) (3) (4) , has become an increasingly common problem in clinics. However, few strategies directed against MIRI have been tested under clinical conditions (5, 6) . Recently, a new finding showed that the pharmacological inhibition of lipid phosphatase and tension homolog on chromosome 10 (PTEN) limited myocardial infarct size and improved left ventricular function post-infarction (7) . Moreover, protein tyrosine phosphatase inhibitors and bisperoxovanadium molecules (bpV) inhibited PTEN specifically at low concentrations (8) . The protective effects of bpV(HOpic) on myocardial injury in vitro and in vivo have been observed in previous studies (7) . However, other bpV molecules have not been studied and compared for their actions against MIRI.
Based on the cellular mechanisms of ischemia/reperfusion injury that have been extensively explored (9) (10) (11) , reactive oxygen species (ROS) generated with the re-admission of oxygen are considered the first and main cause of ischemia/ reperfusion injury (12) . Thus, scavenging excessive ROS and restoring the reduction-oxidation (redox) balance in the body is an important strategy in inhibiting reperfusion injury, as the redox balance is the solid physiological condition in humans from birth (13, 14) , and, despite evolution, this balance has always been conserved in all organisms (15, 16) .
Hydrogen dioxide (H 2 O 2 ), a famous ROS, inhibits the lipid phosphatase activity of the tumour suppressor PTEN enzyme (17) , which suggests that when produced under pathological conditions, such as during MIRI or chronic inflammation, H 2 O 2 may contribute to the inhibition of apoptosis or necrosis and be involved in cardioprotection. However, a comparative study of this phenomenon in different models of ROS production in cardiomyocytes has not yet been conducted.
In the present study, we selected hypoxia/reoxygenation (H/R) and H 2 O 2 -induced cardiomyocyte injury models in H9c2 cardiomyoblasts to investigate and compare the cardioprotective effects of bpV(pic) and bpV(phen), two vanadium compounds and PTEN inhibitors (8) , and to further discuss the different actions of the two selected models on H9c2 cells (Fig. 1 ).
Materials and methods
Reagents. BpV(pic) and bpV(phen) were obtained from Enzo Life Sciences Inc. (Farmingdale, NY, USA). H9c2 cardiomyoblasts were purchased from ATCC (Rockville, MD, USA). Dulbecco's modified Eagle's medium (DMEM) and fetal bovine serum (FBS) were purchased from Gibco (Grand Island, NY, USA). Malachite Green reagent, PTEN enzyme and its substrate PIP 3 were purchased from Echelon Biosciences Inc. Cell culture and treatment. H9c2 cardiomyoblasts were cultured in 100-mm dishes in DMEM containing 4 mM glutamine, 1.5 g/l sodium bicarbonate, 4.5 g/l glucose, 1.0 mM sodium pyruvate, 12% (vol/vol) FBS, 100 U/ml penicillin and 100 U/ml streptomycin. Cells were incubated at 37˚C in a humidified atmosphere containing 95% air, 5% CO 2 . Following trypsinization and washing, cells were seeded in 96-well plates (4x10 3 cells/well) or 60-mm dishes (3x10 5 cells/dish). At ~60% confluence, cells were treated with different concentrations of bpV(pic) or bpV(phen) in DMEM containing 12% (vol/vol) FBS for 24 h. For the H/R model, the medium was replaced with serum-free medium containing 4 mM of Na 2 S 2 O 4 . Following 4 h of incubation, the medium was again replaced with fresh medium containing 12% (vol/vol) FBS. In the second part of the experiments, aimed at assessing the contribution of bpV(pic) and bpV(phen) to the protection against H 2 O 2 -induced cell injury, the medium was supplemented with 50 µM of H 2 O 2 .
Effects of bpV(pic) and bpV(phen) on
Cell viability and morphology analysis were conducted after 4 or 24 h. Control cells were always incubated in DMEM containing 12% (vol/vol) FBS and model group cells were not treated with bpV(pic) or bpV(phen). Cell viability was determined using the colorimetric procedure based on the reduction of a water-soluble tetrazolium salt, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) or CCK-8 using a microplate reader (BioRad, Hercules, CA, USA). H9c2 cell morphology was observed with an inverted microscope (Olympus IX-71, Tokyo, Japan).
Determination of PTEN activity. Recombinant PTEN (rPTEN) activity was determined as follows: 2 µg of rPTEN was incubated initially for 5 min at 37˚C with 50 nM of bpV(pic) or bpV(phen) and then for 30 min with 3 nM of PIP 3 . The reactions were stopped with 80% (vol/vol) of Malachite Green reagent and the released phosphates were measured 20 min later by a colorimetric procedure using a microplate reader (Tecan, Zurich, Switzerland) at 625 nm. PTEN activity was determined by free phosphates released and subsequently converted to a percentage of the control reaction. 
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Measurement of LDH activity. The activity of LDH in H9c2 cardiomyoblasts released into the medium following treatment with H/R or H 2 O 2 was assessed as previously described (18), i.e., by a spectrophotometric analysis at 440 nm using an LDH assay kit, according to the manufacturer's instructions.
Flow cytometry. H9c2 cardiomyoblasts were harvested and resuspended in phosphate-buffered saline (PBS) buffer at a concentration of 1x10 6 cells/ml. Following centrifugation at 1,000 x g for 5 min, 400 µl of FITC-conjugated annexin V binding buffer, 5 µl of annexin V-FITC and 5 µl of propidium iodide (PI) were added. Following gentle vortexing, the sample was analyzed using a dual-laser FACSCanto flow cytometer (Becton-Dickinson, Mountain View, CA, USA) within a 2-h period. The percentage of apoptotic cells for each sample were estimated.
Caspases 3/8/9 activities assay. H9c2 cardiomyoblasts were lysed with lysis buffer on ice for 15 min and the lysates were centrifuged (16,000 x g for 15 min at 4˚C). Subsequently, the protein concentration was determined using the BCA protein assay, and samples (20 µg) of the extracted protein were incubated with 100 µl of the reaction buffer containing 10 µl of caspase substrate (2 mM Ac-DEVD-pNA for caspase 3, Ac-IETD-pNA for caspase 8 and Ac-LEHD-pNA for caspase 9) at 37˚C for 60-120 min in a 96-well plate. Enzymecatalyzed release of p-nitroanilide was measured at 405 nm using a microplate reader.
Statistical analysis. Data obtained from different experiments were shown as the means ± SD from at least three independent experiments, and were evaluated by analysis of variance (ANOVA) followed by the Student-Newman-Keuls test. P<0.05 was considered to indicate statistically significant differences.
Results

Inhibitory effects of bpV(pic) and bpV(phen) on PTEN activity.
To further compare and confirm the inhibitory effects of bpV(pic) and bpV(phen) on PTEN activity, and based on a previous study (19) , we measured PTEN phosphatase activity in the presence of bpV(pic) or bpV(phen) in vitro. Compared C to the control group, both bpV(pic) and bpV(phen) exhibited significant inhibitory effects on PTEN activity (Fig. 2) , however, their inhibitions were different; the inhibitory rate of bpV(pic) was >70% (100 to 23.8%), while that of bpV(phen) was >45% (100 to 54.7%). The inhibitory degrees of these two compounds were in accordance with their IC 50 values on PTEN activity, as previously mentioned (19) .
Effects of bpV(pic) and bpV(phen) on the viability and morphology of normal H9c2 cardiomyoblasts. To investigate the effects of bpV(pic) and bpV(phen) on H9c2 cardiomyoblasts and to obtain a suitable concentration range for subsequent research, the CCK-8 kit was used to assess the viability of H9c2 cardiomyoblasts following treatment with different concentrations of bpV(pic) and bpV(phen) (1-100 µM) for 24 h. The results showed that bpV(pic) and bpV(phen) did not cause any decrease in cell viability with concentrations ranging from 1 to 10 µM. However, compared to the control group, the viability of cells decreased significantly in a concentration-dependent manner from 20 to 100 µM (Fig. 3A) . Moreover, morphological changes were not evident at a low concentration (≤10 µM) of these two compounds, but at a higher concentration (≥50 µM), H9c2 cell growth was inhibited (Fig. 3B) . Thus, a concentration range of 1 to 10 µM of bpV(pic) and bpV(phen) was used for the subsequent investigation.
Effects of bpV(pic) and bpV(phen) on the viability and morphology of H9c2 cardiomyoblasts during H/R and H 2 O 2 treatment.
To investigate and compare the protective effects of bpV(pic) and bpV(phen) on ROS-induced injury in the two models, MTT assay was used to measure the viability of H9c2 cardiomyoblasts during H/R and H 2 O 2 treatment following pre-treatment with different concentrations of bpV(pic) and bpV(phen) (1-10 µM) for 24 h. The data showed that cell viability in the H/R model dropped significantly compared to the control group, and cells treated with bpV(pic) (2-10 µM) or bpV(phen) (1-5 µM) showed a significantly high viability compared to the model group (Fig. 4A) . However, there was a more notable decrease in viability in the H 2 O 2 group compared to the H/R group, and cells treated with bpV(pic) (1-10 µM) or bpV(phen) (1-2 µM) showed a better viability compared to the model group (Fig. 4B) . Moreover, the mortality of H9c2 cardiomyoblasts caused by H/R was evident under the inverted microscope compared to the control group. At the concentration of 2 µM, both bpV(pic) and bpV(phen) protected cells against injury (Fig. 4C) . H 2 O 2 -induced cell injury was more severe compared to that caused by H/R, and again at 2 µM, bpV(pic) and bpV(phen) protected cells against injury.
Effects of bpV(pic) and bpV(phen) on LDH release in H9c2 cardiomyoblasts during H/R and H 2 O 2 treatment.
To further evaluate the protective effects of bpV(pic) and bpV(phen) in H/R and H 2 O 2 models, we measured LDH release as an indicator for necrotic cell death (20) . LDH release from H9c2 cardiomyoblasts in H/R and H 2 O 2 models was increased up to approximately 142.7±18.1 and 156.3±6.7%, respectively, compared to that in the control group (Fig. 5) . H/R-induced cell death was inhibited by pre-treatment with 2 µM of bpV(pic) (61.4±5.1%) or bpV(phen) (70.3±7.7%) for 24 h (Fig. 5A) .
Moreover, H 2 O 2 -induced cell death was inhibited by pretreatment with 2 µM of bpV(pic) (118.9±19.0%) or bpV(phen) (125.5±6.8%) for 24 h (Fig. 5B) .
Effects of bpV(pic) and bpV(phen) on apoptosis in H9c2 cardiomyoblasts during H/R and H 2 O 2 treatment.
To evaluate the anti-apoptotic effects of bpV(pic) and bpV(phen) in the H/R and H 2 O 2 models, the apoptotic rate was quantified by flow cytometry. Apoptotic cell levels increased from 4.3% in the control group to 31.6% in the H/R and 51.8% in the H 2 O 2 group (Fig. 6) . Pre-treatment with 2 µM of bpV(pic) and bpV(phen) for 24 h decreased the apoptotic rate in the H/R group to 6.3 and 14.4%, respectively, and in the H 2 O 2 group to 11.6 and 24.8%, respectively (Fig. 6B) .
Effects of bpV(pic) and bpV(phen) on caspases 3/8/9 activities in H9c2 cardiomyoblasts during H/R and H 2 O 2 treatment.
To determine the underlying cardioprotective mechanism of bpV(pic) and bpV(phen) on H9c2 cardiomyoblast injury during H/R and H 2 O 2 treatment, caspases 3/8/9 activities were measured. The results revealed that bpV(pic) and bpV(phen) inhibited the increased caspases 3/8/9 activities in the H/R and H 2 O 2 models in H9c2 cardiomyoblasts (Fig. 7) . The data also showed that caspases 3/8/9 activities were different in the two models. Caspases 3/8 activities were much higher in H9c2 cardiomyoblasts treated with H 2 O 2 (308.4±41.5 and 250.6±20.7%, respectively) than in those from the H/R group (226.8±9.8 and 170.5±17.9%, respectively), whereas caspase 9 activity varied slightly in the two models (146.4±23.8% in H 2 O 2 and 167.3±26.5% in H/R). Finally, the protective effects of bpV(pic) and bpV(phen) against the injury in the two models were apparent.
Discussion
PTEN, a dual protein-lipid phosphatase, is the major downregulator of the pro-oncogenic PI3K/Akt pathway by degrading phosphatidylinositol 3,4,5-trisphosphate (PIP 3 ) to an inactive form of phosphatidylinositol 4,5-bisphosphate (PIP 2 ), and thus inhibits Akt activation (21) (22) (23) (24) (25) . Overexpression of PTEN increases apoptosis in neonatal cardiomyocytes, whereas the inhibition of PTEN activates the Akt pro-survival pathway, reduces apoptosis and increases cell survival (8,26-28).
Targeting PTEN via pharmacological inhibition may thus provide a new approach for the therapy of MIRI in clinics.
Although there are only a few highly specific PTEN inhibitors, bpV is a relatively specific inhibitor of PTEN (8). Furthermore, bpV(HOpic) has been shown to attenuate simulated ischemia/reperfusion injury in cardiomyocytes, and to limit myocardial infarct size and ameliorate cardiac dysfuction post-infarct in vivo (7) . To further investigate the protective effects of other bpVs on cardiomyocytes, we selected bpV(pic) and bpV(phen) from a list of bpV compounds that have already been tested on PTEN (8) .
H9c2 is a rat-derived cardiomyoblast cell line that exhibits morphological characteristics similar to those of immature embryonic cardiomyocytes, but preserves several elements of the electrical and hormonal signaling pathway found in adult cardiac cells (29, 30) . H9c2 cardiomyoblasts have been widely used to screen active components (31, 32) . To investigate the potency of new inhibitors on MIRI, H/R and H 2 O 2 -induced cell injury models are often used in vitro (33) (34) (35) (36) (37) . Therefore, the two models were also used in our study to evaluate the protective effects of bpV(pic) and bpV(phen).
In the present study, exogenous H 2 O 2 (50 µM) (38,39) and oxygen scavenger Na 2 S 2 O 4 (40) were selected to set up two in vitro chemical models for the study of ROS activity. Based on cell viability, cell morphology, LDH release and the apoptosis assay, we showed that the two in vitro models were different (Figs. 4-6 ). H 2 O 2 -induced injury in H9c2 cells was more severe than H/R from its impact on cell viability and morphology. Additionally, LDH release and apoptosis results were in accordance with the above results, indicating that the induced necrosis in the H 2 O 2 model was more significant than that in the H/R model.
Based on the different inhibitory activities of bpV(pic) and bpV(phen) on PTEN in vitro and their non-toxic concentration range in H9c2 cells (Figs. 2 and 3) , their individual effects on cell viability and morphology in H9c2 cells injured during H/R or H 2 O 2 treatment, were studied. Our data reveal that both bpV(pic) and bpV(phen) significantly protected H9c2 cell injury induced in both models, with high activity of bpV(pic) (Fig. 4) . Moreover, the results of LDH release, apoptosis and caspases 3/8/9 activities confirm the above-mentioned data regarding the cardioprotective activities of bpV(pic) and bpV(phen) that may be relevant to their inhibitory ability on PTEN activity (Figs. 5-7 ).
The present findings have shown that bpV(pic) and bpV(phen) protect H9c2 against ROS-induced injury by inhibiting cell necrosis and apoptosis, and thus potentially protect cardiomyocytes against I/R injury. Their mechanisms probably include three pathways: i) the inhibition of caspases 8 and 3, ii) the inhibition of caspases 9 and 3, and iii) the inhibition of PTEN and the activation of the PI3K/Akt signaling pathway (Fig. 8) .
Apoptosis and necrosis are linked to the excess of intracellular ROS production (41, 42) . H 2 O 2 , as an important ROS, leads to the formation of hydroxyl radicals (OH·) mediated by intracellular heavy metal ions through the Fenton reaction. On the other hand, cells subjected to H/R may produce a large quantity of H 2 O 2 , O 2 -, OH· and other ROS (43, 44) . All ROS induce severe intracellular oxidative stress, which damages various intracellular biomacro-molecules and eventually results in cell apoptosis and necrosis (45) . Moreover, either endogenous H 2 O 2 or endogenous ROS production inhibit PTEN activity (17, 46) . Thus, the different effects of H/R and H 2 O 2 on cell viability are not only relevant to the quantity of ROS, but also to the inhibitory capacity of ROS on the PTEN enzyme, suggesting that the protective effects of bpV(pic) and bpV(phen) against H 2 O 2 and H/R-induced injuries in H9c2 cells are the comprehensive result of actions of the two compounds on the ROS system and PTEN and the action of ROS on PTEN as well.
In the present study, we assessed the protective effects of bpV(pic) and bpV(phen) on ROS-induced injury in H9c2 cardiomyocytes. We also compared the different actions of the two ROS models and discussed the synergetic action of ROS and PTEN inhibitors through the PTEN enzyme, which is likely to be useful in preventing MIRI. Nevertheless, more studies are required to explore ROS balance and its role in health and injury.
